Plasma fibrinogen levels, other cardiovascular risk factors, and age-related maculopathy: the Blue Mountains Eye Study.

PubWeight™: 1.70‹?› | Rank: Top 3%

🔗 View Article (PMID 9596493)

Published in Arch Ophthalmol on May 01, 1998

Authors

W Smith1, P Mitchell, S R Leeder, J J Wang

Author Affiliations

1: National Centre for Epidemiology and Population Health, Australian National University, Sydney.

Articles citing this

Risk factors for the incidence of Advanced Age-Related Macular Degeneration in the Age-Related Eye Disease Study (AREDS) AREDS report no. 19. Ophthalmology (2005) 3.28

Epidemiology of age-related maculopathy: a review. Eur J Epidemiol (2003) 2.32

Clinical risk factors for age-related macular degeneration: a systematic review and meta-analysis. BMC Ophthalmol (2010) 2.32

Obesity and eye diseases. Surv Ophthalmol (2007) 2.13

Age-related macular degeneration and risk of coronary heart disease and stroke: the Cardiovascular Health Study. Ophthalmology (2009) 1.76

Age-Related Macular Degeneration and Coronary Artery Disease in a VA Population. South Med J (2015) 1.40

Ordered subset linkage analysis supports a susceptibility locus for age-related macular degeneration on chromosome 16p12. BMC Genet (2004) 1.27

Cardiovascular disease, its risk factors and treatment, and age-related macular degeneration: Women's Health Initiative Sight Exam ancillary study. Am J Ophthalmol (2007) 1.26

Multicenter prospective, randomized, double-masked, placebo-controlled study of Rheopheresis to treat nonexudative age-related macular degeneration: interim analysis. Trans Am Ophthalmol Soc (2002) 1.23

Inflammation, complement factor h, and age-related macular degeneration: the Multi-ethnic Study of Atherosclerosis. Ophthalmology (2008) 1.22

Body mass index and the incidence of visually significant age-related maculopathy in men. Arch Ophthalmol (2001) 1.17

Genetic markers and biomarkers for age-related macular degeneration. Expert Rev Ophthalmol (2007) 1.15

Design and intermediate results of the Lower Extremity Arterial Disease Event Reduction (LEADER)* trial of bezafibrate in men with lower extremity arterial disease [ISRCTN4119421]. Curr Control Trials Cardiovasc Med (2001) 1.13

Genetic susceptibility to age related macular degeneration. J Med Genet (2000) 1.11

High-sensitivity C-reactive protein, other markers of inflammation, and the incidence of macular degeneration in women. Arch Ophthalmol (2007) 1.10

Nitric oxide and lipid peroxidation are increased and associated with decreased antioxidant enzyme activities in patients with age-related macular degeneration. Doc Ophthalmol (2003) 1.09

The relation between C reactive protein and age related macular degeneration in the Cardiovascular Health Study. Br J Ophthalmol (2005) 1.03

Physical activity and the 15-year cumulative incidence of age-related macular degeneration: the Beaver Dam Eye Study. Br J Ophthalmol (2006) 1.03

Elevated high-density lipoprotein cholesterol and age-related macular degeneration: the Alienor study. PLoS One (2014) 0.99

Inflammation and its role in age-related macular degeneration. Cell Mol Life Sci (2016) 0.97

Combined effects of complement factor H genotypes, fish consumption, and inflammatory markers on long-term risk for age-related macular degeneration in a cohort. Am J Epidemiol (2008) 0.95

Risk factors for age-related maculopathy. J Ophthalmol (2009) 0.95

Parainflammation, chronic inflammation, and age-related macular degeneration. J Leukoc Biol (2015) 0.94

Reconsidering the connection between vitamin D levels and age-related macular degeneration. Eye (Lond) (2011) 0.92

Plasma apolipoproteins and risk for age related maculopathy. Br J Ophthalmol (2006) 0.92

Prospective study of incident age-related macular degeneration in relation to vigorous physical activity during a 7-year follow-up. Invest Ophthalmol Vis Sci (2008) 0.92

Effect of systemic hypertension on foveolar choroidal blood flow in age related macular degeneration. Br J Ophthalmol (2006) 0.91

Cardiovascular risk factors and age-related macular degeneration: the Los Angeles Latino Eye Study. Am J Ophthalmol (2008) 0.91

Identification of human plasma proteins as major clients for the extracellular chaperone clusterin. J Biol Chem (2009) 0.91

Risk factors for four-year incidence and progression of age-related macular degeneration: the los angeles latino eye study. Am J Ophthalmol (2011) 0.88

Diabetes mellitus and risk of age-related macular degeneration: a systematic review and meta-analysis. PLoS One (2014) 0.87

The prevalence and analysis of risk factors for age-related macular degeneration: 18-year follow-up data from the Speedwell eye study, United Kingdom. Eye (Lond) (2011) 0.86

Fibrinogen stimulates in vitro angiogenesis by choroidal endothelial cells via autocrine VEGF. Graefes Arch Clin Exp Ophthalmol (2004) 0.85

Risk factors and biomarkers of age-related macular degeneration. Prog Retin Eye Res (2016) 0.85

Age-related macular degeneration and mortality in community-dwelling elders: the age, gene/environment susceptibility Reykjavik study. Ophthalmology (2014) 0.84

Biological risk of older adults with visual impairments. J Nutr Health Aging (2011) 0.83

Prevalence and risks factors of age-related macular degeneration in Oklahoma Indians: the Vision Keepers Study. Ophthalmology (2011) 0.81

The relationship of atherosclerosis to the 10-year cumulative incidence of age-related macular degeneration: the Beaver Dam studies. Ophthalmology (2013) 0.81

Association between various types of obesity and macular pigment optical density. Eye (Lond) (2012) 0.80

Is age-related macular degeneration associated with stroke among elderly americans? Open Ophthalmol J (2008) 0.80

A randomised controlled trial investigating the effect of nutritional supplementation on visual function in normal, and age-related macular disease affected eyes: design and methodology [ISRCTN78467674]. Nutr J (2003) 0.80

Novel measures of cardiovascular health and its association with prevalence and progression of age-related macular degeneration: the CHARM Study. BMC Ophthalmol (2008) 0.79

The rate of myocardial infarction events among patients with age-related macular degeneration: a population-based study. Graefes Arch Clin Exp Ophthalmol (2010) 0.79

Dietary analysis and patterns of nutritional supplement use in normal and age-related macular disease affected subjects: a prospective cross-sectional study. Nutr J (2004) 0.77

Association of Serum Ferritin and Kidney Function with Age-Related Macular Degeneration in the General Population. PLoS One (2016) 0.77

The association of enzymatic and non-enzymatic antioxidant defense parameters with inflammatory markers in patients with exudative form of age-related macular degeneration. J Clin Biochem Nutr (2017) 0.75

Influence of posterior vitreous detachment and type of intraocular lens on lipid peroxidation in the human vitreous. Mol Vis (2015) 0.75

Effect of High-Density Lipoprotein Metabolic Pathway Gene Variations and Risk Factors on Neovascular Age-Related Macular Degeneration and Polypoidal Choroidal Vasculopathy in China. PLoS One (2015) 0.75

CYP4F2 (rs2108622) Gene Polymorphism Association with Age-Related Macular Degeneration. Adv Med (2016) 0.75

[Age-related macular degeneration and risk of stroke]. J Fr Ophtalmol (2008) 0.75

Fibrinogen and rhegmatogenous retinal detachment: a pilot prospective study. Clin Ophthalmol (2010) 0.75

Articles by these authors

Chemiosmotic coupling in oxidative and photosynthetic phosphorylation. Biol Rev Camb Philos Soc (1966) 17.89

Purified transcription factor AP-1 interacts with TPA-inducible enhancer elements. Cell (1987) 14.62

Effect of fenofibrate on the need for laser treatment for diabetic retinopathy (FIELD study): a randomised controlled trial. Lancet (2007) 6.82

Use of inhaled corticosteroids and the risk of cataracts. N Engl J Med (1997) 6.09

Functions of the exosome in rRNA, snoRNA and snRNA synthesis. EMBO J (1999) 5.68

Visual acuity and the causes of visual loss in Australia. The Blue Mountains Eye Study. Ophthalmology (1996) 5.36

Risk factors for age-related macular degeneration: Pooled findings from three continents. Ophthalmology (2001) 5.06

The yeast exosome and human PM-Scl are related complexes of 3' --> 5' exonucleases. Genes Dev (1999) 4.95

Enhanced cleavage of type II collagen by collagenases in osteoarthritic articular cartilage. J Clin Invest (1997) 4.31

Prevalence of age-related maculopathy in Australia. The Blue Mountains Eye Study. Ophthalmology (1995) 4.28

Acid-base titration across the membrane system of rat-liver mitochondria. Catalysis by uncouplers. Biochem J (1967) 4.24

Proton-coupled beta-galactoside translocation in non-metabolizing Escherichia coli. J Bioenerg (1972) 4.24

Estimation of membrane potential and pH difference across the cristae membrane of rat liver mitochondria. Eur J Biochem (1969) 3.97

Changing prevalence of asthma in Australian children. BMJ (1994) 3.94

The relationship between glaucoma and myopia: the Blue Mountains Eye Study. Ophthalmology (1999) 3.87

Identification of human immunodeficiency virus type 1 Gag protein domains essential to membrane binding and particle assembly. J Virol (1994) 3.85

Translocations through natural membranes. Adv Enzymol Relat Areas Mol Biol (1967) 3.77

Vectorial chemistry and the molecular mechanics of chemiosmotic coupling: power transmission by proticity. Biochem Soc Trans (1976) 3.58

Cooperative hernia study. Pain in the postrepair patient. Ann Surg (1996) 3.57

Influence of family factors on the incidence of lower respiratory illness during the first year of life. Br J Prev Soc Med (1976) 3.55

Possible molecular mechanisms of the protonmotive function of cytochrome systems. J Theor Biol (1976) 3.41

Performance and conservation of osmotic work by proton-coupled solute porter systems. J Bioenerg (1973) 3.41

Keilin's respiratory chain concept and its chemiosmotic consequences. Science (1979) 3.23

Mortality and locomotion 6 months after hospitalization for hip fracture: risk factors and risk-adjusted hospital outcomes. JAMA (2001) 3.13

Translocation of some anions cations and acids in rat liver mitochondria. Eur J Biochem (1969) 3.13

The POP1 gene encodes a protein component common to the RNase MRP and RNase P ribonucleoproteins. Genes Dev (1994) 3.12

Asthma in preschool children: prevalence and risk factors. Thorax (2001) 3.10

Cognitive deficits in depression: possible implications for functional neuropathology. Br J Psychiatry (2001) 3.07

Chemiosmotic coupling in energy transduction: a logical development of biochemical knowledge. J Bioenerg (1972) 3.02

Proton-translocation phosphorylation in mitochondria, chloroplasts and bacteria: natural fuel cells and solar cells. Fed Proc (1967) 2.96

Proton/sodium ion antiport in Escherichia coli. Biochem J (1974) 2.89

Prevalence and causes of amblyopia in an adult population. Ophthalmology (1998) 2.84

Pharmacokinetics of sevoflurane uptake into the brain and body. Anaesthesia (2003) 2.78

Smoking and age-related macular degeneration: a review of association. Eye (Lond) (2005) 2.77

Has evidence changed practice?: appropriateness of carotid endarterectomy after the clinical trials. Neurology (2007) 2.75

The polarity of proton translocation in some photosynthetic microorganisms. Eur J Biochem (1969) 2.74

Stoicheiometry of lactose-H+ symport across the plasma membrane of Escherichia coli. Biochem J (1973) 2.57

Carcinoembryonic antigen in patients with different cancers. JAMA (1972) 2.56

Detection of antibodies to human T-lymphotropic virus type III by using a synthetic peptide of 21 amino acid residues corresponding to a highly antigenic segment of gp41 envelope protein. Proc Natl Acad Sci U S A (1986) 2.54

Visual impairment and falls in older adults: the Blue Mountains Eye Study. J Am Geriatr Soc (1998) 2.51

Cigarette smoking and drug use in schoolchildren: IV--factors associated with changes in smoking behaviour. Int J Epidemiol (1983) 2.50

Degradation of ribosomal RNA precursors by the exosome. Nucleic Acids Res (2000) 2.47

Acid-base titration across the plasma membrane of Micrococcus denitrificans: factors affecting the effective proton conductance and the respiratory rate. J Bioenerg (1970) 2.45

Infection of human dendritic cells by dengue virus causes cell maturation and cytokine production. J Immunol (2001) 2.39

Synthesis and anti-inflammatory effect of chalcones and related compounds. Pharm Res (1998) 2.36

Effect of primary-care spirometry on the diagnosis and management of COPD. Eur Respir J (2006) 2.34

The protonmotive Q cycle: a general formulation. FEBS Lett (1975) 2.32

Refractive errors in an older population: the Blue Mountains Eye Study. Ophthalmology (1999) 2.29

"Smoking is a major cause of blindness". Med J Aust (1999) 2.27

The Ninth Sir Hans Krebs Lecture. Compartmentation and communication in living systems. Ligand conduction: a general catalytic principle in chemical, osmotic and chemiosmotic reaction systems. Eur J Biochem (1979) 2.25

The Vineland Adaptive Behavior Scales: supplementary norms for individuals with autism. J Autism Dev Disord (1998) 2.24

Optimal dietary approaches for prevention of type 2 diabetes: a life-course perspective. Diabetologia (2010) 2.23

Health effects of particulate pollution: reappraising the evidence. Am J Epidemiol (1979) 2.19

Stoichiometry of proton translocation through the respiratory chain and adenosine triphosphatase systems of rat liver mitochondria. Nature (1965) 2.19

Respiration-driven proton translocation in Micrococcus denitrificans. J Bioenerg (1971) 2.17

Visual impairment in nursing home residents: the Blue Mountains Eye Study. Med J Aust (1997) 2.17

Construction and characterization of infectious human T-cell leukemia virus type 1 molecular clones. Virology (1994) 2.14

Outdoor activity and myopia in Singapore teenage children. Br J Ophthalmol (2009) 2.13

Importance of house dust mite and Alternaria allergens in childhood asthma: an epidemiological study in two climatic regions of Australia. Clin Exp Allergy (1993) 2.10

Protonmotive redox mechanism of the cytochrome b-c1 complex in the respiratory chain: protonmotive ubiquinone cycle. FEBS Lett (1975) 2.07

Coronary heart disease epidemics: not all the same. Heart (2008) 2.07

Knowledge and beliefs about common eye diseases. Aust N Z J Ophthalmol (1997) 2.06

Medications and cataract. The Blue Mountains Eye Study. Ophthalmology (1998) 2.05

Amputation and adriamycin in primary osteosarcoma. N Engl J Med (1974) 2.04

Association of pseudoexfoliation syndrome with increased vascular risk. Am J Ophthalmol (1997) 2.03

Sceptical medicine. Med J Aust (1999) 2.02

House dust mites and skin tests in different Australian localities. Aust N Z J Med (1986) 2.00

Validation of self-reported hearing loss. The Blue Mountains Hearing Study. Int J Epidemiol (2001) 2.00

Age-related macular degeneration and mortality from cardiovascular disease or stroke. Br J Ophthalmol (2008) 1.98

British Medical Association enters GM-crop affray. Lancet (1999) 1.94

Vision screening for frail older people: a randomised trial. Br J Ophthalmol (2008) 1.93

Clustering of modified nucleotides at the functional center of bacterial ribosomal RNA. FASEB J (1993) 1.93

Prevalence of diabetic retinopathy in an older community. The Blue Mountains Eye Study. Ophthalmology (1998) 1.93

Prevalence and associations of epiretinal membranes. The Blue Mountains Eye Study, Australia. Ophthalmology (1997) 1.91

2,3-Dihydro-1H-imidazo(1,2-b)pyrazole: a new inhibitor of deoxyribonucleic acid synthesis. Biochem Pharmacol (1971) 1.88

Risk factors for age-related maculopathy: the Visual Impairment Project. Arch Ophthalmol (2001) 1.88

Influence of family factors on asthma and wheezing during the first five years of life. Br J Prev Soc Med (1976) 1.86

Diabetes and risk of fracture: The Blue Mountains Eye Study. Diabetes Care (2001) 1.84

Retinopathy in older persons without diabetes and its relationship to hypertension. Arch Ophthalmol (1998) 1.84

A selection test for Australian graduate-entry medical schools. Med J Aust (1997) 1.83

Transcriptional activation by Myc is under negative control by the transcription factor AP-2. EMBO J (1995) 1.82

Retinopathy predicts coronary heart disease mortality. Heart (2008) 1.80

Getting new evidence into medicine. Med J Aust (2000) 1.79

The relationship between glaucoma and pseudoexfoliation: the Blue Mountains Eye Study. Arch Ophthalmol (1999) 1.78

The development of performance and cost indicators for preschool immunisation. Arch Dis Child (1986) 1.77

Pharmacogenetic interactions between beta-blocker therapy and the angiotensin-converting enzyme deletion polymorphism in patients with congestive heart failure. Circulation (2001) 1.76

How safe are Australian hospitals? Med J Aust (1995) 1.75

Asthma morbidity in Australia: an epidemiological study. Med J Aust (1992) 1.74

Retinal microvascular signs and risk of stroke and stroke mortality. Neurology (2005) 1.74

Pharmacokinetics of desflurane uptake into the brain and body. Anaesthesia (2004) 1.71

Impact of visual impairment on use of community support services by elderly persons: the Blue Mountains Eye Study. Invest Ophthalmol Vis Sci (1999) 1.70

Propofol and ECT. Br J Psychiatry (1992) 1.68

Energy-ubiquitin-dependent muscle proteolysis during sepsis in rats is regulated by glucocorticoids. J Clin Invest (1996) 1.67